½ÃÀ庸°í¼­
»óǰÄÚµå
1604781

¼¼°èÀÇ ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çü, ¿ë·®, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº°¿¹Ãø(2025-2030³â)

Automated Sample Storage System Market by Product Type (Reagents & Consumables, Storage System Units), Capacity (100K - 500K Samples, 500K - 2M Samples, Less Than 100K Samples), Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 4¾ï 4,450¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â¿¡´Â 5¾ï 788¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµÇ¸ç º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 14.74%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 11¾ï 6,404¸¸ ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ(ASSS)ÀÇ ¹üÀ§¿Í Á¤ÀÇ´Â ¿¬±¸ ¹× ó¸® ½Ã¼³¿¡¼­ »ý¹°ÇÐÀû, È­ÇÐÀû ¹× ±âŸ ½Ã·á¸¦ º¸°ü ¹× °ü¸®Çϵµ·Ï ¼³°èµÈ ½Ã½ºÅÛÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½Ã·á¸¦ Ãë±ÞÇϰí ȯ°æ Á¶°ÇÀ» Á¦¾îÇÏ¿© ½Ã·á ¹«°á¼ºÀ» À¯ÁöÇϸç ÀϹÝÀûÀ¸·Î ¿Âµµ °ü¸®, °Ë»ö ¹× ÃßÀû ±â´ÉÀ» Æ÷ÇÔÇÕ´Ï´Ù. ¿À ±×¸®°í »ý¼º ¹× ÀúÀåµÇ´Â µ¥ÀÌÅÍÀÇ ¾çÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀÎ »ùÇà °ü¸®¿¡ ´ëÇÑ ¿ä±¸°¡ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù. µî ´Ù¹æ¸é¿¡ °ÉÃÄ Á¤È®ÇÑ ½Ã·á °ü¸®, »ý»ê¼º Çâ»ó, ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö °¨¼Ò¸¦ ½ÇÇöÇÕ´Ï´Ù. µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 4¾ï 4,450¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 5¾ï 788¸¸ ´Þ·¯
¿¹Ãø³â(2030³â) 11¾ï 6,404¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 14.74%

½ÃÀåÀÇ ÁÖ¿ä ÇÏÀ̶óÀÌÆ®´Â »ý¸í°úÇÐÀÇ Áøº¸, °Ë»ç½Ç¿¡¼­ÀÇ ÀÚµ¿È­ µµÀÔ Áõ°¡, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ ÁؼöÀÇ Çʿ伺 µîÀÇ ÁÖ¿ä ¼ºÀå ¿äÀÎÀÔ´Ï´Ù. Á¤±³ÇÑ º¸°ü ¼Ö·ç¼ÇÀÇ Çʿ伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ½ÃÀå °³Ã´Àº º¸°ü ½Ã½ºÅÛÀÇ ¿¹Áö º¸ÀüÀ» À§ÇÑ AI ÅëÇÕ, ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» À§ÇÑ IoTÀÇ ÅëÇÕ, °Ë»ç½Ç ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÖ´Â ½ÅÈï±¹ ½ÃÀå¿¡ ÁøÃâ°ú °°Àº Çõ½Å¿¡ ÀÖ½À´Ï´Ù.

±×·¯³ª Ãʱ⠼³Á¤ ºñ¿ëÀÇ ³ôÀÌ, ½Ã½ºÅÛ ÅëÇÕÀÇ º¹À⼺, ÀÌ·¯ÇÑ °í±Þ ½Ã½ºÅÛÀ» Á¶ÀÛÇÏ´Â ¼÷·ÃÀÚÀÇ Çʿ伺 µîÀÇ Á¦¾àÀÌ ÀÖ½À´Ï´Ù. ¼º°ú Á¤È®¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ±Øº¹ÇÏ´Â °Íµµ µµÀüÀÔ´Ï´Ù.

ºñÁî´Ï½º ¼ºÀå°ú Çõ½ÅÀ» À§Çؼ­´Â ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç °³¹ß, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¹× °æÇè Çâ»ó, ±¹Á¦ Ç¥ÁØ Áؼö º¸Àå¿¡ ÁßÁ¡À» µÎ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ³ª´Ï ÀÌ¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÚµ¿ ÇÁ·Î¼¼½º¿Í ¼öµ¿ ÇÁ·Î¼¼½º¸¦ °áÇÕÇÑ ÇÏÀ̺긮µå ½Ã½ºÅÛÀ» ¸ð»öÇÒ ¼öµµ ÀÖ´Ù°í »ý°¢µË´Ï´Ù.

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÚµ¿ »ùÇà ÀúÀå ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸÀÇ È¹µæ¿¡ ´ëºñÇÏ´Â °Í ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ ±×¸®°í ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °¢Á¾ ¾Ï, ¸é¿ª ÁúȯÀÇ À¯º´·ü Áõ°¡, °í·ÉÀÚ Áõ°¡
    • ÀÓ»ó ¿¬±¸¼Ò ¹× Á¦¾à ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • ¹ÙÀÌ¿À¹ðÅ© °Ç¼³¿¡ ´ëÇÑ Á¤ºÎ Áö¿ø Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº À¯Áöºñ¿Í ¼³Ä¡ ºñ¿ë
  • ½ÃÀå ±âȸ
    • »ý¸í°úÇÐ ¹× Á¦¾à»ê¾÷¿¡¼­ ¾×¼Ç¼ö Áõ°¡
    • °úÇÐ ½ÇÇèÀ» ½Ç½ÃÇϱâ À§ÇÑ Àΰ£ »ýü Àç·áÀÇ ÀÌ¿ëÀÇ °¡¼ÓÈ­
  • ½ÃÀåÀÇ °úÁ¦
    • ½Ã·áÀÇ ¹«°á¼º°ú ½Å¼ÓÇÑ È¸¼ö¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : ÀÚµ¿ »ùÇà ÀúÀå ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÚµ¿ »ùÇà ÀúÀå ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

ÀÚµ¿ »ùÇà ½ºÅ丮Áö ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÚµ¿ »ùÇà ÀúÀå ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÚµ¿ »ùÇà ½ºÅ丮Áö ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ ÀÇ»ç°áÁ¤ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´Ù¾çÇÑ ¾ÏÀ̳ª ¸é¿ª Áúȯ Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡
      • ÀÓ»ó ½ÇÇè½Ç°ú Á¦¾à ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • ¹ÙÀÌ¿À¹ðÅ© ±¸Ãà¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿ø Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • À¯Áö º¸¼ö ¹× ¼³Ä¡ ºñ¿ëÀÌ ³ô½À´Ï´Ù
    • ±âȸ
      • »ý¸í°úÇÐ ¹× Á¦¾à»ê¾÷¿¡¼­ÀÇ ¾×¼Ç Áõ°¡
      • °úÇÐ ½ÇÇèÀ» ½Ç½ÃÇϱâ À§ÇÑ Àΰ£ »ýü Àç·áÀÇ ÀÌ¿ëÀÇ ÃËÁø
    • °úÁ¦
      • ½Ã·áÀÇ ¹«°á¼º°ú ½Å¼ÓÇÑ È¸¼ö¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼Ò°³
  • ½Ã¾à ¹× ¼Ò¸ðǰ
  • º¸°ü ½Ã½ºÅÛ À¯´Ö

Á¦7Àå ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå : ¿ë·®º°

  • ¼Ò°³
  • 10¸¸-50¸¸ »ùÇÃ
  • 50¸¸-200¸¸ »ùÇÃ
  • 10¸¸ »ùÇà ÀÌÇÏ
  • 200¸¸ »ùÇà ÀÌ»ó

Á¦8Àå ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • »ý¹° »ùÇÃÀÇ º¸°ü
  • È­ÇÐ È­ÇÕ¹°ÀÇ º¸°ü

Á¦9Àå ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • Çмú¿¬±¸¼Ò
  • ¹ÙÀÌ¿À¹ðÅ©
  • Á¦¾à, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÚµ¿ »ùÇà º¸°ü ½Ã½ºÅÛ ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Angelantoni Life Science
  • Askion GmbH
  • Azenta US, Inc.
  • Beckman Coulter, Inc.
  • Biolab Scientific Ltd.
  • Caron Products & Services, Inc.
  • Celltrio, Inc.
  • Daifuku Co. Ltd.
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Guoyuan Life Science Group Co. Ltd.
  • Haier Biomedical Co. Ltd.
  • Hamilton Company
  • HighRes Biosolutions
  • Honeywell International Inc.
  • Inpeco SA
  • LiCONiC AG
  • Micronic
  • Panasonic Healthcare Co, Ltd.
  • Sampled
  • SPT Labtech
  • Swisslog Holding Ltd.
  • Thermo Fisher Scientific Inc.
  • Tsubaki Group
  • TTP Labtech
BJH 24.12.16

The Automated Sample Storage System Market was valued at USD 444.50 million in 2023, expected to reach USD 507.88 million in 2024, and is projected to grow at a CAGR of 14.74%, to USD 1,164.04 million by 2030.

The scope and definition of the Automated Sample Storage System (ASSS) encompass systems designed to store and manage biological, chemical, or other samples in research and processing facilities. These systems automatically handle samples, maintaining their integrity by controlling environmental conditions and typically include temperature management, retrieval, and tracking functionalities. The necessity for ASSS arises from the increasing demand for efficient sample management in laboratories, biobanks, and healthcare institutions due to the growing amount of data generated and stored in these facilities. Its applications span across pharmaceutical research, biotechnology, genomics, and clinical research, offering precise sample management, enhanced productivity, and reduced manual handling errors. The system's end-use scope includes academic/research institutes, hospitals/clinical laboratories, and biopharmaceutical companies.

KEY MARKET STATISTICS
Base Year [2023] USD 444.50 million
Estimated Year [2024] USD 507.88 million
Forecast Year [2030] USD 1,164.04 million
CAGR (%) 14.74%

Market insights highlight key growth factors such as the ongoing advancements in life sciences, increasing adoption of automation in laboratories, and the need to comply with rigorous regulatory standards. Moreover, the rise in research activities, especially post the COVID-19 pandemic, has accentuated the need for sophisticated storage solutions. Potential opportunities lie in innovations like integrating AI for predictive maintenance of storage systems, incorporating IoT for real-time monitoring, and expanding into emerging markets with developing laboratory infrastructure.

However, limitations include high initial setup costs, complexity of system integration, and the need for skilled personnel to operate these sophisticated systems. Challenges also come from ensuring data security and overcoming concerns regarding the system's reliability and accuracy over long-term storage.

For business growth and innovation, focusing on developing cost-effective solutions, enhancing user interface and experience, and ensuring compliance with international standards will be pivotal. R&D areas could explore hybrid systems combining automated and manual processes to cater to diverse needs. The market is dynamic, with a trend towards adopting more sustainable and energy-efficient storage systems, offering insights into shifting preferences, which businesses can leverage for strategic planning.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Automated Sample Storage System Market

The Automated Sample Storage System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of various cancers, immunological disorders, and increasing geriatric population
    • Growing investments in the clinical laboratories and pharma fields
    • Rising government support for constructing biobanks
  • Market Restraints
    • High maintenance and installation cost
  • Market Opportunities
    • Proliferating number of actions in life science and pharmaceutical industries
    • Accelerating use of human biomaterials for performing scientific experiments
  • Market Challenges
    • Concerns regarding sample integrity and rapid retrieval

Porter's Five Forces: A Strategic Tool for Navigating the Automated Sample Storage System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Automated Sample Storage System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Automated Sample Storage System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Automated Sample Storage System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Automated Sample Storage System Market

A detailed market share analysis in the Automated Sample Storage System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Automated Sample Storage System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Automated Sample Storage System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Automated Sample Storage System Market

A strategic analysis of the Automated Sample Storage System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Sample Storage System Market, highlighting leading vendors and their innovative profiles. These include Angelantoni Life Science, Askion GmbH, Azenta US, Inc., Beckman Coulter, Inc., Biolab Scientific Ltd., Caron Products & Services, Inc., Celltrio, Inc., Daifuku Co., Ltd., Eppendorf SE, F. Hoffmann-La Roche AG, Guoyuan Life Science Group Co., Ltd., Haier Biomedical Co. Ltd., Hamilton Company, HighRes Biosolutions, Honeywell International Inc., Inpeco SA, LiCONiC AG, Micronic, Panasonic Healthcare Co, Ltd., Sampled, SPT Labtech, Swisslog Holding Ltd., Thermo Fisher Scientific Inc., Tsubaki Group, and TTP Labtech.

Market Segmentation & Coverage

This research report categorizes the Automated Sample Storage System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Reagents & Consumables and Storage System Units.
  • Based on Capacity, market is studied across 100K - 500K Samples, 500K - 2M Samples, Less Than 100K Samples, and Over 2M Samples.
  • Based on Application, market is studied across Biological Sample Storage and Chemical Compound Storage.
  • Based on End User, market is studied across Academic Research Labs, Biobanks, and Pharma & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of various cancers, immunological disorders, and increasing geriatric population
      • 5.1.1.2. Growing investments in the clinical laboratories and pharma fields
      • 5.1.1.3. Rising government support for constructing biobanks
    • 5.1.2. Restraints
      • 5.1.2.1. High maintenance and installation cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferating number of actions in life science and pharmaceutical industries
      • 5.1.3.2. Accelerating use of human biomaterials for performing scientific experiments
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding sample integrity and rapid retrieval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Automated Sample Storage System Market, by Product Type

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Storage System Units

7. Automated Sample Storage System Market, by Capacity

  • 7.1. Introduction
  • 7.2. 100K - 500K Samples
  • 7.3. 500K - 2M Samples
  • 7.4. Less Than 100K Samples
  • 7.5. Over 2M Samples

8. Automated Sample Storage System Market, by Application

  • 8.1. Introduction
  • 8.2. Biological Sample Storage
  • 8.3. Chemical Compound Storage

9. Automated Sample Storage System Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Labs
  • 9.3. Biobanks
  • 9.4. Pharma & Biotech Companies

10. Americas Automated Sample Storage System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Automated Sample Storage System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Automated Sample Storage System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Angelantoni Life Science
  • 2. Askion GmbH
  • 3. Azenta US, Inc.
  • 4. Beckman Coulter, Inc.
  • 5. Biolab Scientific Ltd.
  • 6. Caron Products & Services, Inc.
  • 7. Celltrio, Inc.
  • 8. Daifuku Co., Ltd.
  • 9. Eppendorf SE
  • 10. F. Hoffmann-La Roche AG
  • 11. Guoyuan Life Science Group Co., Ltd.
  • 12. Haier Biomedical Co. Ltd.
  • 13. Hamilton Company
  • 14. HighRes Biosolutions
  • 15. Honeywell International Inc.
  • 16. Inpeco SA
  • 17. LiCONiC AG
  • 18. Micronic
  • 19. Panasonic Healthcare Co, Ltd.
  • 20. Sampled
  • 21. SPT Labtech
  • 22. Swisslog Holding Ltd.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Tsubaki Group
  • 25. TTP Labtech
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦